论文部分内容阅读
慢性心力衰竭患者的交感神经系统活性增强,随着病程的延长可导致心血管系统功能恶化,β受体阻滞剂可通过抑制神经内分泌的活性而预防病情恶化。β受体阻滞剂治疗慢性心力衰竭在我国得到广泛应用,我国紧跟国际研究的前沿,开展了大量的临床研究工作,积累了丰富的临床经验。国内研究表明,合理使用β受体阻滞剂可有效改善心力衰竭患者的预后。
Sympathetic nervous system activity is enhanced in patients with chronic heart failure, with the course of the disease can lead to deterioration of cardiovascular system function, β-blockers can prevent neuroendocrine activity and prevent disease progression. β blockers in the treatment of chronic heart failure has been widely used in our country, our country closely follow the forefront of international research, carried out a large number of clinical research work, has accumulated rich clinical experience. Domestic research shows that the rational use of β-blockers can effectively improve the prognosis of patients with heart failure.